More tools:Markets·Screener·Research Chat

Abbott Laboratories (ABT) Financial Statements

Abbott Laboratories
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001S5N9M6
XNYS · usd
88.96▼ 3.15 (-3.42%)
As of 2026-07-14
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)$45.1B
Net Income (TTM)$6.3B
EBITDA
Diluted EPS (TTM)
EBITDA Margin24.1%
Net Debt
Trading Information
Previous Close92.11
Day's Range88.62 – 90.50
52-Week Range81.97 – 137.49
Volume12.46M
Avg Volume12.77M
Share Statistics
Shares Outstanding1.7B
Employees115.0K
ExchangeXNYS
Listed1949-04-19

Key questions about Abbott Laboratories (ABT)

What is Abbott Laboratories's Market Cap?
Abbott Laboratories's Market Cap is $155.0B, based on as-reported figures from SEC (XBRL) filings.
What is Abbott Laboratories's Enterprise Value?
Abbott Laboratories's Enterprise Value is $164.4B, based on as-reported figures from SEC (XBRL) filings.
What is Abbott Laboratories's Trailing P/E?
Abbott Laboratories's Trailing P/E is 24.7×, based on as-reported figures from SEC (XBRL) filings.
What is Abbott Laboratories's Price / Sales?
Abbott Laboratories's Price / Sales is 3.4×, based on as-reported figures from SEC (XBRL) filings.
What is Abbott Laboratories's EV / Revenue?
Abbott Laboratories's EV / Revenue is 3.6×, based on as-reported figures from SEC (XBRL) filings.
What is Abbott Laboratories's EV / EBITDA?
Abbott Laboratories's EV / EBITDA is 15.1×, based on as-reported figures from SEC (XBRL) filings.
What is Abbott Laboratories's Revenue (TTM)?
Abbott Laboratories's Revenue (TTM) is $45.1B, based on as-reported figures from SEC (XBRL) filings.
What is Abbott Laboratories's Net Income (TTM)?
Abbott Laboratories's Net Income (TTM) is $6.3B, based on as-reported figures from SEC (XBRL) filings.
What is Abbott Laboratories's EBITDA?
Abbott Laboratories's EBITDA is $10.9B, based on as-reported figures from SEC (XBRL) filings.
What is Abbott Laboratories's Diluted EPS (TTM)?
Abbott Laboratories's Diluted EPS (TTM) is 3.60, based on as-reported figures from SEC (XBRL) filings.
Loading Income Statement…
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022
Net sales
YoY growth+7.8%+4.4%+6.9%+7.4%
Cost of products sold, excluding amortization of intangible assets
Amortization of intangible assets
Research and development
Selling, general, and administrative
Total operating cost and expenses
% of revenue88.0%80.4%81.9%81.6%
Income (loss) from operations
% of revenue12.0%19.6%18.1%18.4%
Interest expense
Interest (income)
Net foreign exchange (gain) loss
Other (income) expense, net
Income (loss) before income taxes
Income tax expense (benefit)
Net income (loss)
% of revenue9.6%15.5%14.5%16.0%
Basic Earnings Per Common Share
Diluted Earnings Per Common Share
Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share
Dilutive Common Stock Options————
Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options
Outstanding Common Stock Options Having No Dilutive Effect————